Acadia Healthcare Company, Inc.
ACHC
$66.12
-$0.61-0.91%
| Weiss Ratings | ACHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Reward Grade | C- | |||
| Rating Factors | ACHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Fair | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | ACHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.78 | |||
| Price History | ACHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.04% | |||
| 30-Day Total Return | -10.89% | |||
| 60-Day Total Return | -14.44% | |||
| 90-Day Total Return | -6.83% | |||
| Year to Date Total Return | -10.20% | |||
| 1-Year Total Return | -5.17% | |||
| 2-Year Total Return | 4.52% | |||
| 3-Year Total Return | 13.94% | |||
| 5-Year Total Return | 117.65% | |||
| 52-Week High % Change | -16.40% | |||
| 52-Week Low % Change | 10.36% | |||
| Price | ACHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $87.77 | |||
| 52-Week Low Price | $66.49 | |||
| 52-Week Low Price (Date) | Oct 06, 2023 | |||
| 52-Week High Price (Date) | Feb 27, 2024 | |||
| Valuation | ACHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 6.48B | |||
| Enterprise Value | 8.00B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.26 | |||
| Earnings Per Share Growth | -108.59% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 2.20 | |||
| Price/Book (Q) | 2.30 | |||
| Enterprise Value/Revenue (TTM) | 2.83 | |||
| Price | $70.28 | |||
| Enterprise Value/EBITDA (TTM) | 12.99 | |||
| Enterprise Value/EBIT | 16.38 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | ACHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 91.87M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ACHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 615 861 6000 | |||
| Address | 6100 Tower Circle Franklin, TN 37067 | |||
| Website | www.acadiahealthcare.com | |||
| Country | United States | |||
| Year Founded | 2005 | |||
| Profitability | ACHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 17.29% | |||
| Profit Margin | -0.73% | |||
| Management Effectiveness | ACHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 6.12% | |||
| Return on Equity | -- | |||
| Income Statement | ACHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 2.93B | |||
| Total Revenue (TTM) | 2.93B | |||
| Revenue Per Share | $31.88 | |||
| Gross Profit (TTM) | 1.25B | |||
| EBITDA (TTM) | 638.95M | |||
| EBIT (TTM) | 506.60M | |||
| Net Income (TTM) | -21.67M | |||
| Net Income Avl. to Common (TTM) | -21.67M | |||
| Total Revenue Growth (Q YOY) | 10.00% | |||
| Earnings Growth (Q YOY) | -5.37% | |||
| EPS Diluted (TTM) | -0.26 | |||
| EPS Diluted Growth (Q YOY) | -6.32% | |||
| Balance Sheet | ACHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 100.07M | |||
| Cash Per Share (Q) | $1.09 | |||
| Total Current Assets (Q) | 596.00M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 2.89B | |||
| Current Ratio (Q) | 0.673 | |||
| Book Value Per Share (Q) | $30.48 | |||
| Total Assets (Q) | 5.36B | |||
| Total Current Liabilities (Q) | 885.78M | |||
| Total Debt (Q) | 1.51B | |||
| Total Liabilities (Q) | 2.47B | |||
| Total Common Equity (Q) | 2.78B | |||
| Cash Flow | ACHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -397.22M | |||
| Cash from Financing (TTM) | -62.70M | |||
| Net Change in Cash (TTM) | 2.42M | |||
| Levered Free Cash Flow (TTM) | 411.35M | |||
| Cash from Operations (TTM) | 462.34M | |||
